Mariana Figueiredo Rodrigues was not included as an author in the published article. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
multidrug resistance, glycolysis, glyceraldehyde-3-phosphate dehydrogenase, leukemia, reactive oxygen species
Citation
Vidal RS, Quarti J, Rodrigues MF, Rumjanek FD and Rumjanek VM (2018) Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias. Front. Oncol. 8:441. doi: 10.3389/fonc.2018.00441
Received
20 September 2018
Accepted
21 September 2018
Published
12 November 2018
Approved by
Frontiers in Oncology Editorial Office, Frontiers Media SA, Switzerland
Volume
8 - 2018
Updates
Copyright
© 2018 Vidal, Quarti, Rodrigues, Rumjanek and Rumjanek.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vivian M. Rumjanek vivian@bioqmed.ufrj.br
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.